Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $48.4900 (-1.12%) ($47.3900 - $48.4900) on Wed. Feb. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.22% (three month average) | RSI | 36 | Latest Price | $48.4900(-1.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.9% a day on average for past five trading days. | Weekly Trend | TGTX declines -2.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(67%) ARKG(63%) ARKK(59%) IBB(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -3.11% in a week (0% probabilities). VIXM(-41%) VXX(-36%) UUP(-19%) UNG(-3%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.11% (StdDev 6.22%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $41.27(-14.89%) | Inflection Point | Yes | Resistance Level | $50.12 | 5 Day Moving Average | $48.52(-0.06%) | 10 Day Moving Average | $48.6(-0.23%) | 20 Day Moving Average | $50.12(-3.25%) | To recent high | -11.4% | To recent low | 80.1% | Market Cap | $6.141b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |